Last update:

HIV & AIDS news

Medications

Gilead licenses HIV-prevention drug to generic drugmakers

US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

Ban says world on way to 'generation free of AIDS'

UN Secretary-General Ban Ki-moon said Tuesday the world was headed for a "generation free of AIDS", after UNAIDS reported a 35-percent drop in new HIV infections from 15 years ago.

HIV & AIDS

More women, children now on lifesaving HIV treatment worldwide

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds today's announcement from the Joint United Nations Programme on HIV/AIDS (UNAIDS) that the goal of providing 15 million people with lifesaving antiretroviral ...

HIV & AIDS

Towards an HIV vaccine

Neutralizing antibodies (Nabs) are immune proteins that recognize, bind to, and trigger the elimination of virus before it can establish a chronic infection. How to elicit a potent Nab response capable of protecting against ...

HIV & AIDS

Researcher detects traces of HIV in the city

Since the treatment has become available, HIV is often described as "undetectable" and the risk of transmission has been drastically reduced. However, the epidemic is still quite present in the lives of many gay and bisexual ...

HIV & AIDS

Fears 11,000 Australian dental patients exposed to HIV

Up to 11,000 Australian dental patients were urged to see their doctors Thursday over fears they may have been exposed to HIV and hepatitis due to hygiene breaches at clinics in Sydney.

HIV & AIDS

Stem cell gene therapy holds promise for eliminating HIV infection

cientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are one step closer to engineering a tool that could one day arm the body's immune system to fight HIV—and win. The new technique ...

HIV & AIDS

CDC examines prevalence of undiagnosed HIV

(HealthDay)—Many people have undiagnosed HIV, with the prevalence varying by geographic area, according to a report published in the June 26 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality ...

HIV & AIDS

Potential new HIV therapy seen in immune cells

A research team led by Weill Cornell Medical College scientists has discovered a way to limit replication of the most common form of HIV at a key moment when the infection is just starting to develop. The study, published ...

HIV & AIDS

More secondary schooling reduces HIV risk

Longer secondary schooling substantially reduces the risk of HIV infection—especially for girls—and could be a very cost-effective way to halt the spread of the virus, according to researchers from Harvard T.H. Chan School ...

HIV & AIDS

Bill Gates hopeful of AIDS vaccine in 10 years

Billionaire and philanthropist Bill Gates, who spends millions of dollars on AIDS drug development, said Friday he hoped for a vaccine against the disease within the next decade as a cure remains far off.

HIV & AIDS

PrEP is not linked to greater risk for depression

A new paper out of the iPrEx study—a randomized, placebo-controlled trial of daily oral HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men—reported no link between taking Truvada for ...